Evomonoside
Evomonoside is a type of cardiac glycoside compound. Evomonoside exhibits significant in vitro anticancer activity, especially having nanomolar inhibitory concentrations against gastric cancer cell lines. Evomonoside has typical cardiac toxicity risks, including arrhythmias and conduction abnormalities. Evomonoside can be used for research on gastric cancer[1].
Product Specifications
CAS Number
508-93-0
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Cancer; Cardiovascular Disease
Smiles
O[C@@]12[C@@]3([H])[C@@](CC[C@@]1([C@@H](C(CO4)=CC4=O)CC2)C)([H])[C@@]5([C@](C[C@H](CC5)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)([H])CC3)C
Molecular Formula
C29H44O8
Molecular Weight
520.65
References & Citations
[1]Hyun JW, et al. Evomonoside: the cytotoxic cardiac glycoside from Lepidium apetalum. Planta Med. 1995 Jun;61 (3) :294-5.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Itsn1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Lentiviral mouse Tnfrsf10b shRNA (UAS) - Lentiviral mouse Tnfrsf10b shRNA (UAS, RFP) plasmid
